← Directory

Star51 Capital

VC · New York · United States

Email
Website
LinkedIn
Founded
2025
Ticket
$5-10 m

Stages

Series BSeries ASeedPre-seedLate Stage (Series C+)

Investment region

North AmericaEuropeMiddle East

Industries

DigitalHealthcare ServicesMedical DevicesAIMedTechHealthTech

Profile

Star51 Capital is a venture investment platform focused on the intersection of Medtech and AI. The firm is anchored by a leading healthcare system and a global Medtech strategic, and it was founded by operators with extensive experience in building and scaling Medtech companies. The team is comprised of founders turned investors who leverage their industry expertise to bridge the gap between innovation and acquisition. The firm invests in sectors related to Medtech, specifically in therapies, diagnostics, monitoring, and the personalization and digitalization of healthcare delivery. Star51 Capital sources high-conviction opportunities from the US, Europe, and Israel, aiming to create companies that are both acquirable and in high demand. The firm is operator-led and focuses on building an integrated ecosystem that enhances market entry and liquidity for its portfolio companies. Notable investments include Corindus Vascular Robotics - acquired by Siemens Healthineers, and partnerships with Abbott and Mayo Clinic for their inaugural fund. The firm emphasizes collaboration and aims to generate competitive returns while making a lasting impact on patient care.

Contatti (2)

NomeTitleEmailTelefonoLinkedIn
Founding Managing Partner — — —
Founding Managing Partner — — —

Name, email and phone are partially hidden. Subscribe to see them in full.